Trial Evaluating the Efficacy and Safety of 2 Fixed Doses of Paliperidone Extended-Release (ER) Tablets in the Treatment of Adult Patients With Schizophrenia

This study has been completed.

Study NCT00077714 Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

First Received: February 11, 2004 Last Updated: March 24, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	January 2005
Estimated Primary Completion Date:	No date given